Home
Hildegunn Siv Aase's picture
  • E-mailHildegunn.Aase@uib.no
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • 2019. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial. The Lancet Oncology. 795-805.
  • 2019. Screening at stationary versus mobile units in BreastScreen Norway. Journal of Medical Screening.
  • 2019. Breast compression parameters among women screened with standard digital mammography and digital breast tomosynthesis in a randomized controlled trial . Acta Radiologica. 1-14.
  • 2018. A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial. European Radiology.
  • 2016. Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival. Journal of Clinical Pathology. 313-319.
  • 2016. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. European Radiology. 1-7.
  • 2012. Hormone therapy use and mammographic density in postmenopausal Norwegian women. Breast Cancer Research and Treatment. 297-305.
  • 2010. Immediate treatment versus sonographic surveillance for mild hip dysplasia in newborns. Pediatrics. E9-E16.
Academic lecture
  • 2019. Early Performance Measures Among Women Screened with DBT after a Prior DBT or a Prior DM, in a National Screening Program.
Reader opinion piece
  • 2014. Re: Mammografiscreening bør avvikles. Tidsskrift for Den norske legeforening. 1545.
Abstract
  • 2010. Association of mammographic density with selected nutrients in Norwegian women. European Journal of Cancer. 14-15.
Poster
  • 2019. Neoadjuvant olaparib monotherapy in primary triple negative breast cancer.
  • 2019. Neoadjuvant endocrine therapy with palbociclib in patients with high-risk breast cancer.
  • 2011. Hormone therapy use and mammographic density in postmenopausal norwegian women: a cross-sectional study.

More information in national current research information system (CRIStin)